Consolidated cash flow statements
(thousands of €) |
2022 |
2021 |
Notes |
---|---|---|---|
Net loss of the year |
(217,991) |
(103,231) |
|
|
|
|
|
Adjustment for non-cash transactions |
117,296 |
57,718 |
|
Adjustment for items to disclose separately under operating cash flow |
(4,533) |
11,227 |
|
Adjustment for items to disclose under investing and financing cash flows |
(3,789) |
(28,847) |
|
Change in working capital other than deferred income |
32,313 |
23,337 |
|
Cash used for other liabilities related to the acquisition of subsidiaries |
(28,164) |
- |
|
Decrease in deferred income |
(383,618) |
(453,720) |
|
|
|
|
|
Cash used in operations |
(488,487) |
(493,516) |
|
|
|
|
|
Interest paid |
(12,463) |
(12,540) |
|
Interest received |
4,839 |
2,913 |
|
Corporate taxes paid |
(4,433) |
(684) |
|
|
|
|
|
Net cash flow used in operating activities |
(500,544) |
(503,827) |
|
|
|
|
|
Purchase of property, plant and equipment |
(27,389) |
(54,205) |
|
Purchase of and expenditure in intangible fixed assets |
(9,558) |
(3,674) |
|
Proceeds from disposal of property, plant and equipment |
739 |
- |
|
Purchase of current financial investments |
(2,728,634) |
(1,561,015) |
|
Interest received related to current financial investments |
2,996 |
12 |
|
Sale of current financial investments |
1,641,602 |
2,127,380 |
|
Cash in from disposals of subsidiaries, net of cash disposed of |
- |
28,696 |
|
Cash out from acquisition of subsidiaries, net of cash acquired |
(115,270) |
- |
|
Cash advances and loans to third parties |
(10,000) |
- |
|
Proceeds from sale of financial assets held at fair value through profit or loss |
- |
4,045 |
|
|
|
|
|
Net cash flow generated from/used in (-) investing activities |
(1,245,514) |
541,238 |
|
|
|
|
|
Payment of lease liabilities |
(8,182) |
(7,190) |
|
Proceeds from capital and share premium increases from exercise of subscription rights |
6,695 |
3,314 |
|
|
|
|
|
Net cash flow used in financing activities |
(1,487) |
(3,876) |
|
|
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,747,545) |
33,535 |
|
Cash and cash equivalents at beginning of year |
2,233,368 |
2,143,071 |
|
|
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,747,545) |
33,535 |
|
|
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
22,293 |
56,763 |
|
|
|
|
|
Cash and cash equivalents at end of the year |
508,117 |
2,233,368 |
The accompanying notes form an integral part of these financial statements.